Skip to content

Drug interactions

Fedratinib + Ticagrelor

Severity: Moderate

Fedratinib and Ticagrelor: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Fedratinib is a moderate CYP3A4 inhibitor and may increase ticagrelor exposure. This could increase bleeding risk and dyspnea.

What this interaction means in plain words

Fedratinib and Ticagrelor can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Fedratinib belongs to Oncology; Ticagrelor belongs to Cardiovascular.

Evidence level: Low

Why it happens

Inhibition of CYP3A4-mediated ticagrelor metabolism by fedratinib.

What to do

Monitor for bleeding and ticagrelor adverse effects, including platelet counts since fedratinib may cause thrombocytopenia. Consider an alternative P2Y12 inhibitor if bleeding occurs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Fedratinib and Ticagrelor, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Fedratinib with Ticagrelor?

MediHelp rates the interaction as moderate. Fedratinib and Ticagrelor can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Fedratinib is a moderate CYP3A4 inhibitor and may increase ticagrelor exposure. This could increase bleeding risk and dyspnea.

How serious is the interaction between Fedratinib and Ticagrelor?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for bleeding and ticagrelor adverse effects, including platelet counts since fedratinib may cause thrombocytopenia. Consider an alternative P2Y12 inhibitor if bleeding occurs.

What other medicines interact with Ticagrelor?

MediHelp also lists interactions of Ticagrelor with, for example, Itraconazole, Ketoconazole, Levoketoconazole. The full list is on the Ticagrelor page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in